NCT00115193View on ClinicalTrials.gov

Pegfilgrastim Administered on the Same Day as Chemotherapy in Non-Hodgkin's Lymphoma

PHASE2CompletedINTERVENTIONAL
Enrollment

77

Participants

Timeline

Start Date

February 28, 2003

Primary Completion Date

August 31, 2005

Study Completion Date

August 31, 2005

Conditions
Non-Hodgkin's Lymphoma
Interventions
DRUG

pegfilgrastim

pegfilgrastim 6 mg on day 1 of each cycle (within 4 hours of chemotherapy completion)

DRUG

pegfilgrastim

pegfilgrastim 6 mg on day 2 of each cycle (at least 24 hours after chemotherapy completion)

Sponsors

Lead Sponsor

Amgen
All Listed Sponsors
lead

Amgen

INDUSTRY

NCT00115193 - Pegfilgrastim Administered on the Same Day as Chemotherapy in Non-Hodgkin's Lymphoma | Biotech Hunter | Biotech Hunter